1
2
3
4
5
6
7 LONG TITLE
8 General Description:
9 This bill modifies provisions related to certain prescription drugs and schools.
10 Highlighted Provisions:
11 This bill:
12 ▸ defines terms;
13 ▸ allows certain health care providers to provide a prescription upon request to certain
14 school employees or a school nurse for epinephrine and albuterol;
15 ▸ requires the Department of Health and Human Services to issue standing
16 prescription drug orders for epinephrine and albuterol;
17 ▸ waives liability for certain persons; and
18 ▸ makes technical and conforming changes.
19 Money Appropriated in this Bill:
20 None
21 Other Special Clauses:
22 This bill provides a special effective date.
23 Utah Code Sections Affected:
24 AMENDS:
25 26B-4-401, as renumbered and amended by Laws of Utah 2023, Chapter 307
26 26B-4-409, as renumbered and amended by Laws of Utah 2023, Chapter 307
27 26B-4-410, as renumbered and amended by Laws of Utah 2023, Chapter 307
28 58-17b-1005, as last amended by Laws of Utah 2020, Fifth Special Session, Chapter 4
29
30 Be it enacted by the Legislature of the state of Utah:
31 Section 1. Section 26B-4-401 is amended to read:
32 26B-4-401. Definitions.
33 As used in this part:
34 (1) "Agent" means a coach, teacher, employee, representative, or volunteer.
35 (2) (a) "Amateur sports organization" means, except as provided in Subsection (2)(b):
36 (i) a sports team;
37 (ii) a public or private school;
38 (iii) a public or private sports league;
39 (iv) a public or private sports camp; or
40 (v) any other public or private organization that organizes, manages, or sponsors a
41 sporting event for its members, enrollees, or attendees.
42 (b) "Amateur sports organization" does not include a professional:
43 (i) team;
44 (ii) league; or
45 (iii) sporting event.
46 (3) "Anaphylaxis" means a potentially life-threatening hypersensitivity to a substance.
47 (a) Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty
48 breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
49 (b) Causes of anaphylaxis may include insect sting, food allergy, drug reaction, and
50 exercise.
51 (4) "Asthma action plan" means a written plan:
52 (a) developed with a school nurse, a student's parent or guardian, and the student's
53 health care provider to help control the student's asthma; and
54 (b) signed by the student's:
55 (i) parent or guardian; and
56 (ii) health care provider.
57 (5) "Asthma emergency" means an episode of respiratory distress that may include
58 symptoms such as wheezing, shortness of breath, coughing, chest tightness, or breathing
59 difficulty.
60 (6) "Child" means an individual who is under the age of 18.
61 (7) "Department health care provider" means a health care provider who is acting in the
62 capacity of a health care provider during employment for the department.
63 [
64 that contains a measured, single dose of epinephrine that is used to treat a person suffering a
65 potentially fatal anaphylactic reaction.
66 [
67 (a) a physician under Title 58, Chapter 67, Utah Medical Practice Act;
68 (b) a physician under Title 58, Chapter 68, Utah Osteopathic Medical Practice Act;
69 (c) an advanced practice registered nurse under Section 58-31b-302; or
70 (d) a physician assistant under Title 58, Chapter 70a, Utah Physician Assistant Act.
71 [
72 [
73 58-17b-102.
74 [
75 (13) "Public school" means a district school or a charter school.
76 [
77 (a) is [
78 (b) (i) for purposes of administering an epinephrine auto-injector, has successfully
79 completed the training program established in Section 26B-4-407; and
80 (ii) for purposes of administering stock albuterol, has successfully completed the
81 training program established in Section 26B-4-408.
82 [
83 (a) means a facility or organization that employs, contracts with, or has a similar
84 relationship with a qualified adult who is likely to have contact with another person who may
85 experience anaphylaxis; and
86 (b) includes:
87 (i) recreation camps;
88 (ii) an education facility, school, or university;
89 (iii) a day care facility;
90 (iv) youth sports leagues;
91 (v) amusement parks;
92 (vi) food establishments;
93 (vii) places of employment; and
94 (viii) recreation areas.
95 [
96 (a) is licensed under Title 58, Occupations and Professions; and
97 (b) may evaluate and manage a concussion within the health care provider's scope of
98 practice.
99 [
100 employs, contracts with, or has a similar relationship with a qualified adult who is likely to
101 have contact with another person who may experience an asthma emergency.
102 [
103 organized, managed, or sponsored by an organization:
104 (i) a game;
105 (ii) a practice;
106 (iii) a sports camp;
107 (iv) a physical education class;
108 (v) a competition; or
109 (vi) a tryout.
110 (b) "Sporting event" does not include:
111 (i) the issuance of a lift ticket or pass by a ski resort, the use of the ticket or pass, or a
112 ski or snowboarding class or school at a ski resort, unless the skiing or snowboarding is part of
113 a camp, team, or competition that is organized, managed, or sponsored by the ski resort;
114 (ii) as applied to a government entity, merely making available a field, facility, or other
115 location owned, leased, or controlled by the government entity to an amateur sports
116 organization or a child, regardless of whether the government entity charges a fee for the use;
117 or
118 (iii) free play or recess taking place during school hours.
119 [
120 (a) used to treat asthma; and
121 (b) that may be delivered through a device, including:
122 (i) an inhaler; or
123 (ii) a nebulizer with a mouthpiece or mask.
124 [
125 trauma, an acceleration force, or a deceleration force, with one of the following observed or
126 self-reported conditions attributable to the injury:
127 (a) transient confusion, disorientation, or impaired consciousness;
128 (b) dysfunction of memory;
129 (c) loss of consciousness; or
130 (d) signs of other neurological or neuropsychological dysfunction, including:
131 (i) seizures;
132 (ii) irritability;
133 (iii) lethargy;
134 (iv) vomiting;
135 (v) headache;
136 (vi) dizziness; or
137 (vii) fatigue.
138 Section 2. Section 26B-4-409 is amended to read:
139 26B-4-409. Authority to obtain and use an epinephrine auto-injector or stock
140 albuterol.
141 [
142
143
144
145 [
146 [
147 (1) The school district physician, a department health care provider, the medical
148 director of the local health department, or the local emergency medical services director may
149 provide a prescription for the following if requested by a qualified adult, who is a teacher or
150 other school employee at a public or private primary or secondary school in the state, or a
151 school nurse:
152 (a) epinephrine auto-injectors for use in accordance with this part; or
153 (b) stock albuterol for use in accordance with this part.
154 (2) (a) A qualified adult may obtain an epinephrine auto-injector for use in accordance
155 with this part that is dispensed by:
156 (i) a pharmacist as provided under Section 58-17b-1004; or
157 (ii) a pharmacy intern as provided under Section 58-17b-1004.
158 (b) A qualified adult may obtain stock albuterol for use in accordance with this part
159 that is dispensed by:
160 (i) a pharmacist as provided under Section 58-17b-1004; or
161 (ii) a pharmacy intern as provided under Section 58-17b-1004.
162 (3) A qualified adult:
163 (a) may immediately administer an epinephrine auto-injector to a person exhibiting
164 potentially life-threatening symptoms of anaphylaxis when a physician is not immediately
165 available; and
166 (b) shall initiate emergency medical services or other appropriate medical follow-up in
167 accordance with the training materials retained under Section 26B-4-407 after administering an
168 epinephrine auto-injector.
169 (4) If a school nurse is not immediately available, a qualified adult:
170 (a) may immediately administer stock albuterol to an individual who:
171 (i) has a diagnosis of asthma by a health care provider;
172 (ii) has a current asthma action plan on file with the school; and
173 (iii) is showing symptoms of an asthma emergency as described in the student's asthma
174 action plan; and
175 (b) shall initiate appropriate medical follow-up in accordance with the training
176 materials retained under Section 26B-4-408 after administering stock albuterol.
177 (5) (a) A qualified entity that complies with Subsection (5)(b) or (c), may obtain a
178 supply of epinephrine auto-injectors or stock albuterol, respectively, from a pharmacist under
179 Section 58-17b-1004, or a pharmacy intern under Section 58-17b-1004 for:
180 (i) storing:
181 (A) the epinephrine auto-injectors on the qualified epinephrine auto-injector entity's
182 premises; and
183 (B) stock albuterol on the qualified stock albuterol entity's premises; and
184 (ii) use by a qualified adult in accordance with Subsection (3) or (4).
185 (b) A qualified epinephrine auto-injector entity shall:
186 (i) designate an individual to complete an initial and annual refresher training program
187 regarding the proper storage and emergency use of an epinephrine auto-injector available to a
188 qualified adult; and
189 (ii) store epinephrine auto-injectors in accordance with the standards established by the
190 department in Section 26B-4-411.
191 (c) A qualified stock albuterol entity shall:
192 (i) designate an individual to complete an initial and annual refresher training program
193 regarding the proper storage and emergency use of stock albuterol available to a qualified
194 adult; and
195 (ii) store stock albuterol in accordance with the standards established by the department
196 in Section 26B-4-411.
197 Section 3. Section 26B-4-410 is amended to read:
198 26B-4-410. Immunity from liability.
199 (1) The following, if acting in good faith, are not liable in any civil or criminal action
200 for any act taken or not taken under the authority of Sections 26B-4-406 through 26B-4-411
201 with respect to an anaphylactic reaction, or asthma emergency:
202 (a) a qualified adult;
203 (b) a physician, pharmacist, or any other person or entity authorized to prescribe or
204 dispense prescription drugs;
205 (c) a person who conducts training described in Section 26B-4-407 or 26B-4-408;
206 (d) a qualified epinephrine auto-injector entity; [
207 (e) a qualified stock albuterol entity[
208 (f) the department;
209 (g) a local health department;
210 (h) a local education agency; and
211 (i) a local emergency medical services entity.
212 (2) Section 53G-9-502 does not apply to the administration of an epinephrine
213 auto-injector or stock albuterol in accordance with this part.
214 (3) This section does not eliminate, limit, or reduce any other immunity from liability
215 or defense against liability that may be available under state law.
216 Section 4. Section 58-17b-1005 is amended to read:
217 58-17b-1005. Standing prescription drug orders for epinephrine auto-injectors
218 and stock albuterol.
219 [
220
221
222
223 [
224
225 [
226
227 [
228
229 [
230
231 [
232 [
233 [
234
235
236 (1) As used in this section:
237 (a) "Epinephrine protocol" means a protocol that:
238 (i) requires a physician to specify the persons, by professional license number,
239 authorized to dispense the epinephrine auto-injector;
240 (ii) requires a physician to review at least annually the dispensing practices of the
241 persons authorized by the physician to dispense the epinephrine auto-injector;
242 (iii) requires those authorized by a physician to dispense the epinephrine auto-injector
243 to make and retain a record of each dispensing, including:
244 (A) the name of the qualified adult or qualified epinephrine auto-injector entity to
245 whom the epinephrine auto-injector is dispensed;
246 (B) a description of the epinephrine auto-injector dispensed; and
247 (C) other relevant information; and
248 (iv) is approved by the division through rule made in accordance with Title 63G,
249 Chapter 3, Utah Administrative Rulemaking Act, in collaboration with the Physicians
250 Licensing Board created in Section 58-67-201 and the board.
251 (b) "Stock albuterol protocol" means a protocol that:
252 (i) requires a physician to specify the persons, by professional license number,
253 authorized to dispense the stock albuterol;
254 (ii) requires a physician to review at least annually the dispensing practices of the
255 persons authorized by the physician to dispense the stock albuterol;
256 (iii) requires those authorized by the physician to dispense the stock albuterol to make
257 and retain a record of each dispensing, including:
258 (A) the name of the qualified adult or qualified stock albuterol entity to whom the
259 stock albuterol is dispensed;
260 (B) a description of the stock albuterol dispensed; and
261 (C) other relevant information; and
262 (iv) is approved by the division through rule made in accordance with Title 63G,
263 Chapter 3, Utah Administrative Rulemaking Act, in collaboration with the Physicians
264 Licensing Board created in Section 58-67-201 and the board.
265 [
266
267
268
269 [
270
271 [
272
273 [
274
275 [
276
277 [
278 [
279 [
280
281
282 (2) Under Section 58-17b-1004, the Department of Health and Human Services shall
283 have a physician acting in the physician's capacity as an employee of the Department of Health
284 and Human Services issue a standing prescription drug order authorizing the dispensing of:
285 (a) an epinephrine auto-injector in accordance with an epinephrine protocol; and
286 (b) stock albuterol in accordance with a stock albuterol protocol.
287 (3) Under Section 58-17b-1004, a medical director of a local health department may
288 issue a standing prescription drug order authorizing the dispensing of:
289 (a) an epinephrine auto-injector in accordance with an epinephrine protocol; or
290 (b) stock albuterol in accordance with a stock albuterol protocol.
291 Section 5. Effective date.
292 This bill takes effect on August 1, 2024.